Prohibits covered entities in the State from entering into contracts with drug manufacturers that limit the covered entities' use of contract pharmacies. Voids contract provisions for certain drugs if the provisions are based on the maximum allowable cost payment model. Authorizes the attorney general to bring a civil action for violations.
- Chamber
- House
- Introduced
- Jan 17, 2025
- Last action
- Jan 17, 2025 — Pending introduction.
- Session
- 2026
- Momentum
- 46 · Moderate